BlackRock’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.5M Buy
5,433,233
+1,353,033
+33% +$18.6M ﹤0.01% 2275
2025
Q4
$56.3M Buy
4,080,200
+349,206
+9% +$8.21M ﹤0.01% 2447
2025
Q3
$91.2M Buy
3,730,994
+328,147
+10% +$7.99M ﹤0.01% 2156
2025
Q2
$78.6M Buy
3,402,847
+529,888
+18% +$14M ﹤0.01% 2204
2025
Q1
$77.6M Buy
2,872,959
+147,146
+5% +$5.55M ﹤0.01% 2143
2024
Q4
$146M Buy
2,725,813
+303,177
+13% +$16M ﹤0.01% 1846
2024
Q3
$110M Buy
2,422,636
+78,629
+3% +$3.42M ﹤0.01% 2029
2024
Q2
$98.2M Buy
2,344,007
+650,016
+38% +$30.5M ﹤0.01% 2037
2024
Q1
$63.8M Sell
1,693,991
-68,110
-4% -$1.48M ﹤0.01% 2309
2023
Q4
$18.9M Buy
1,762,101
+122,522
+7% +$1.06M ﹤0.01% 3043
2023
Q3
$16.5M Buy
1,639,579
+444,991
+37% +$5.13M ﹤0.01% 3055
2023
Q2
$14.2M Buy
1,194,588
+59,943
+5% +$801K ﹤0.01% 3241
2023
Q1
$13.7M Buy
1,134,645
+31,590
+3% +$526K ﹤0.01% 3159
2022
Q4
$14.5M Sell
1,103,055
-147,293
-12% -$2.16M ﹤0.01% 3196
2022
Q3
$16.9M Buy
1,250,348
+41,994
+3% +$561K ﹤0.01% 3124
2022
Q2
$14.8M Buy
1,208,354
+46,633
+4% +$552K ﹤0.01% 3264
2022
Q1
$16.7M Buy
1,161,721
+153,460
+15% +$2.51M ﹤0.01% 3289
2021
Q4
$19.9M Buy
1,008,261
+206,483
+26% +$4.33M ﹤0.01% 3277
2021
Q3
$17.3M Buy
801,778
+691,831
+629% +$19.9M ﹤0.01% 3381
2021
Q2
$2.74M Buy
+109,947
New +$2.45M ﹤0.01% 4135

Other funds holding JANX